Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Mengling, Thilo  [Clear All Filters]
Journal Article
Punzel M, Medd P, Hunter H, Cunningham R, Pottinger B, Burde B, Widera M, Quade A, Ehninger G, Kozlova A, et al. Detection of HBV DNA in the blood of a stem cell donor after G-CSF treatment. Hepatology. 2016.
Schmidt AH, Sauter J, Baier DM, Daiss J, Keller A, Klussmeier A, Mengling T, Rall G, Riethmüller T, Schöfl G, et al. Immunogenetics in stem cell donor registry work: The DKMS example (Part 2). Int J Immunogenet. 2020.
Szer J, Elmoazzen H, Fechter M, Hwang W, Korhonen M, Miller J, Mengling T, Shaw B, Stein J. Safety of Living Donation of Hematopoietic Stem Cells. Transplantation. 2016.
Pawson R, Anthias C, Cody M, Fechter M, Fournier D, O'Flaherty E, Oliviera D, van Eerden E, Mengling T. SERIOUS STEM CELL DONATION EVENTS AND RECIPIENT ADVERSE REACTIONS RELATED TO SARS-CoV-2: REVIEW OF REPORTS TO THE WORLD MARROW DONOR ASSOCIATION. Transplant Cell Ther. 2023.
Mengling T, Rall G, Bernas SN, Astreou N, Bochert S, Boelk T, Buk D, Burkard K, Endert D, Gnant K, et al. Stem cell donor registry activities during the COVID-19 pandemic: a field report by DKMS. Bone Marrow Transplant. 2020.
Worel N, Aljurf M, Anthias C, Buser AS, Cody M, Fechter M, Galeano S, Greinix HT, Kisch AM, Koh MBC, et al. Suitability of haematopoietic cell donors: updated consensus recommendations from the WBMT standing committee on donor issues. Lancet Haematol. 2022;9(8):e605-e614.